Cingulate Inc (CING)
0.7895
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7895
0.00 (0.00%)
After-Hours: 20:00
Cingulate Enterprise Value: 3.735M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.735M |
| May 16, 2024 | 3.663M |
| May 15, 2024 | 3.663M |
| May 14, 2024 | 3.784M |
| May 13, 2024 | 3.668M |
| May 10, 2024 | 3.488M |
| May 09, 2024 | 4.237M |
| May 08, 2024 | 4.256M |
| May 07, 2024 | 4.248M |
| May 06, 2024 | 4.151M |
| May 03, 2024 | 4.719M |
| May 02, 2024 | 5.658M |
| May 01, 2024 | 5.174M |
| April 30, 2024 | 4.432M |
| April 29, 2024 | 4.171M |
| April 26, 2024 | 4.208M |
| April 25, 2024 | 3.965M |
| April 24, 2024 | 4.147M |
| April 23, 2024 | 4.199M |
| April 22, 2024 | 4.243M |
| April 19, 2024 | 4.202M |
| April 18, 2024 | 4.207M |
| April 17, 2024 | 4.037M |
| April 16, 2024 | 3.784M |
| April 15, 2024 | 3.602M |
| Date | Value |
|---|---|
| April 12, 2024 | 4.456M |
| April 11, 2024 | 3.704M |
| April 10, 2024 | 3.900M |
| April 09, 2024 | 3.947M |
| April 08, 2024 | 3.947M |
| April 05, 2024 | 4.047M |
| April 04, 2024 | 4.247M |
| April 03, 2024 | 4.247M |
| April 02, 2024 | 4.247M |
| April 01, 2024 | 4.348M |
| March 28, 2024 | 8.459M |
| March 27, 2024 | 8.409M |
| March 26, 2024 | 8.509M |
| March 25, 2024 | 8.509M |
| March 22, 2024 | 8.760M |
| March 21, 2024 | 8.174M |
| March 20, 2024 | 8.174M |
| March 19, 2024 | 8.174M |
| March 18, 2024 | 8.319M |
| March 15, 2024 | 8.416M |
| March 14, 2024 | 8.755M |
| March 13, 2024 | 8.900M |
| March 12, 2024 | 8.900M |
| March 11, 2024 | 8.949M |
| March 08, 2024 | 8.755M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.374M
Minimum
Mar 08 2022
48.76M
Maximum
Dec 08 2021
9.678M
Average
8.656M
Median
Jul 05 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.972M |
| Total Expenses (Quarterly) | 2.948M |
| EPS Diluted (Quarterly) | -0.60 |
| Earnings Yield | -2.99K% |